CCRN:NGS-Cross Country Healthcare Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 17.14

Change

0.00 (0.00)%

Market Cap

USD 0.49B

Volume

0.21M

Analyst Target

USD 8.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cross Country Healthcare Inc is a provider of healthcare recruiting, staffing, & workforce solutions. Its workforce solutions include managed service programs, electronic medical record transition staffing, recruitment process outsourcing, among others.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-0.60 (-0.51%)

USD 6.67B
ACHC Acadia Healthcare Company Inc

-0.15 (-0.21%)

USD 6.66B
OPCH Option Care Health Inc

-0.03 (-0.10%)

USD 5.24B
AMED Amedisys Inc

-0.10 (-0.10%)

USD 3.12B
SGRY Surgery Partners Inc

-0.71 (-2.67%)

USD 3.11B
LFST Lifestance Health Group Inc

+0.31 (+4.52%)

USD 2.62B
AMEH Astrana Health Inc.

N/A

USD 1.86B
ADUS Addus HomeCare Corporation

+1.31 (+1.20%)

USD 1.79B
ASTH Astrana Health Inc

+0.26 (+0.67%)

USD 1.77B
HCSG Healthcare Services Group Inc

+0.17 (+1.53%)

USD 0.80B

ETFs Containing CCRN

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.29% 40% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.29% 40% F 22% F
Trailing 12 Months  
Capital Gain -22.02% 46% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.02% 46% F 32% F
Trailing 5 Years  
Capital Gain 135.12% 100% F 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 135.12% 100% F 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 42.69% 82% B 89% A-
Dividend Return 42.69% 82% B 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 80.21% 21% F 20% F
Risk Adjusted Return 53.22% 86% B+ 82% B
Market Capitalization 0.49B 64% D 66% D+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.36 95% 75%
Price/Book Ratio 1.29 77% 61%
Price / Cash Flow Ratio 2.35 58% 44%
Price/Free Cash Flow Ratio 4.62 56% 36%
Management Effectiveness  
Return on Equity 15.61% 96% 85%
Return on Invested Capital 16.09% 94% 86%
Return on Assets 9.00% 97% 94%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.